US President's Emergency Plan for AIDS Relief (PEPFAR), the global HIV response has entered a second year of structural ...

The US has committed a $5.88-billion spending package to the global response to HIV, one year after severe Pepfar funding ...

The R26 billion is expected to be shared among provinces. “R26 billion is allocated to provinces to bolster our HIV/Aids ...

Finance Minister Enoch Godongwana revealed a significant R26 billion allocation to enhance HIV/AIDS programmes, alongside R410 million redirected to sustain vital research funding.

A new study led by researchers from the CUNY Institute for Implementation Science in Population Health (ISPH) finds that the ...

Zimbabwe has launched lenacapavir, an HIV prevention drug administered biannually, aiming to curb infections. While offering ...

Zimbabwe is one of the world's first countries to roll out lenacapavir, a long-acting HIV prevention drug that is ...

A single-pill treatment to suppress HIV proved as effective as existing therapies of up to 11 tablets daily, the latest advance in a scientific “golden age” for treating the virus even as rich ...

Dar es Salaam. Health practitioners in Tanzania are optimistic after the official registration of Lenacapavir, a long-acting ...

Dar es Salaam. Tanzania has officially registered Lenacapavir, a long-acting injectable drug for the prevention and control of HIV, marking what officials describe as a significant milestone in the ...

Uganda is among the top 10 high-burden countries selected to access the injectable through support from the US President’s Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund ...